| CXZB1400014 | 黄芩素片 | Scutellarein | Tablet | Chinese Herbal Medicine | Supplementary Application | 2014-09-12 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2017-05-22 | view |
| CXZB1700010 | 黄芩素片 | Scutellarein | Tablet | Chinese Herbal Medicine | Supplementary Application | 2017-10-26 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2018-03-26 | view |
| CXZB1700009 | 黄芩素 | Scutellarein | Active ingredient | Chinese Herbal Medicine | Supplementary Application | 2017-10-26 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2018-03-26 | view |
| CXZB1400013 | 黄芩素 | Scutellarein | Active ingredient | Chinese Herbal Medicine | Supplementary Application | 2014-09-12 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2017-05-22 | view |
| CXHL1400750 | 马来酸阿法替尼片 | Afatinib Dimaleate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-06-25 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2016-03-17 | view |
| CXHL1400524 | 马来酸阿法替尼片 | Afatinib Dimaleate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-05-22 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2016-02-29 | view |
| CXHL1400751 | 马来酸阿法替尼片 | Afatinib Dimaleate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-06-25 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2016-03-17 | view |
| CXHL1400523 | 马来酸阿法替尼 | Afatinib Dimaleate | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2014-05-22 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2016-02-29 | view |
| X0405332 | 马来酸左旋氨氯地平口腔崩解片 | levamlodipine maleate | Tablet | Chemical Drugs(5) | New Drug Application | 2004-09-20 | 中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2005-08-26 | view |
| X0405331 | 马来酸左旋氨氯地平口腔崩解片 | levamlodipine maleate | Tablet | Chemical Drugs(5) | New Drug Application | 2004-09-20 | 中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2005-08-26 | view |
| CYHS1100885 | 雷贝拉唑钠肠溶胶囊 | rabeprazole sodium | Capsule | Chemical Drugs(6) | Generic Drug | 2011-12-01 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2015-10-28 | view |
| CYHS1100886 | 雷贝拉唑钠肠溶胶囊 | rabeprazole sodium | Capsule | Chemical Drugs(6) | Generic Drug | 2011-12-01 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2015-10-28 | view |
| CXHL1500179 | 阿普司特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXHL1500181 | 阿普司特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXHL1500180 | 阿普司特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXHL1500178 | 阿普司特 | apremilast | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2016-05-11 | view |
| CYSB1300047 | 重组胰高血糖素样肽-1受体激动剂注射液 | | Injection | Biological Products | Supplementary Application | 2013-07-18 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXSB1900009 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products | Supplementary Application | 2019-04-30 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2019-06-03 | view |
| CXSL2000352 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-12-14 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | In Review | 2020-12-10 | view |
| CXSL2000351 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-12-14 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | In Review | 2020-12-10 | view |
